Secondly, whole-of-government approaches may identify, review, and address health system resilience. The three top-ranked recommendations suggest a whole-of-society action and vaccines-plus strategy.įirst, pandemic preparedness and response must adopt a whole-of-society approach, including multiple actors, disciplines, and sectors. The study yielded 41 statements and 57 recommendations to end the COVID-19 pandemic. In the present study, researchers conducted a Delphi study to develop a consensus on ongoing COVID-19 challenges with a diverse multinational panel of 386 experts from 112 countries and territories. Despite the advances, there is heterogeneity in the responses of individual countries partly due to the lack of coordination and goals. Knowledge of COVID-19 etiology, pathophysiology, vaccination, treatment, prevention, and care has advanced rapidly through scientific/medical research, collaboration, and debate. Many people and governments do not have the same level of concern as during the early pandemic however, public health authorities regard COVID-19 as a dangerous and persistent health threat. Nearly three years since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified, pandemic fatigue may undermine the vigilance and efficacy of responses to the associated challenges. Image Credit: Roman Samborskyi/Shutterstock Study: A multinational Delphi consensus to end the COVID-19 public health threat. Ribosomes read the code and build the protein, and the cells express the protein in the body.By Tarun Sai Lomte Reviewed by Aimee MolineuxĪ recent study published in Nature recommended specific actions to end the coronavirus disease 2019 (COVID-19) pandemic. ![]() Once the mRNA is in the cell, human biology takes over. The vaccine is simply delivering a specific mRNA sequence to our cells. The Pfizer vaccine is asking people’s bodies to do something they do every day: protein synthesis, the process where cells make proteins. When Moderna, another coronavirus mRNA vaccine that is now approved and that works very similar to the Pfizer vaccine, was just finishing its Phase I trial, The Independent wrote about the vaccine and described it this way: “It uses a sequence of genetic RNA material produced in a lab that, when injected into your body, must invade your cells and hijack your cells’ protein-making machinery called ribosomes to produce the viral components that subsequently train your immune system to fight the virus.” These vaccines use a sequence of genetic RNA material produced in a lab that, when injected, enters the cells and sparks production of the viral components that subsequently train the immune system to fight the virus. ![]() Pfizer’s vaccine is based on messenger RNA (mRNA) - the first-ever vaccine of this type brought to market for human recipients. Most people simply experience slight pain at the sight of injection, but others can experience some flu-like symptoms that could even affect their ability to carry out normal daily activities. Pfizer side effects usually start within a day or two of receiving the shot and can last for equally as long. The world’s first approved messenger RNA (mRNA) vaccine, it is administered in two doses of 30 micrograms given 21 days apart.Ī Phase III clinical trial found that the Pfizer coronavirus vaccine is 95% effective at preventing laboratory-confirmed coronavirus with minimal side effects. Pfizer’s coronavirus vaccine received approval for emergency use by the American Food and Drug Administration (FDA) - known as Emergency Use Authorization (EUA) - in December 2020. The company’s CEO is Albert Bourla, who was born and raised in Thessaloniki, Greece. According to its website, Pfizer’s global portfolio includes medicines and vaccines, as well as many of the world's best-known consumer health care products. Pfizer (traded as PFE on the New York stock exchange) was founded 170 years ago and is one of the world’s leading biopharmaceutical companies. Israel has embarked on a mass coronavirus vaccination campaign largely centered on the vaccine developed by Pfizer and BioNTech, the company’s German technology partner. NOTE! Consider delaying until first div on page ![]() If (slot) slot.addService(googletag.pubads()) (function (a, d, o, r, i, c, u, p, w, m) Israel's Pfizer Vaccine - Tracker and News | The Jerusalem Post
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |